IRS Penalties Proper In $11B Amgen Dispute, Tax Court Says
The Internal Revenue Service properly authorized penalties included in a tax bill of nearly $11 billion that drugmaker Amgen is challenging, the U.S. Tax Court said Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article